CD8A and Epstein-Barr virus infection: Vigorous EBV-specific CD4+ and CD8+ T cell responses are expanded early in AIM [23], [24], [25]; several lines of evidence suggest that these cellular immune responses are important for limiting primary EBV infection and controlling chronic infection such that diseases associated with EBV are relatively rare.